Orange Book product · Brand (NDA)
XCOPRI
CENOBAMATE
Brand (NDA)NDA 212839RX SK LIFE
At a glance
Mar 10, 2020
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 10, 2020
6 yr 4 mo ago
Today
Patent 7598279 expires
Listed drug substance patent expiration.
Oct 30, 2032
in 6 yr 6 mo
Patent 11654133 expires
Listed method-of-use patent (U-3610) expiration.
Jun 16, 2039
in 13 yr 2 mo
Pharmaceutical detail
Active ingredient
CENOBAMATE
Strength
12.5MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 212839
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7598279 | Oct 30, 2032 | in 6 yr 6 mo | Substance |
| 11654133 | Jun 16, 2039 | in 13 yr 2 mo | U-3610 |
